1 Vousden K., "p53 in health and disease" 8 : 275-283, 2007
2 Hussain SP, "p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis" 73 : 54-64, 2006
3 Bradley RL, "Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice" 295 : E586-E594, 2008
4 Zaken V., "Vitamins C and E improve rat embryonic antioxidant defense mechanism in diabetic culture medium" 64 : 33-44, 2001
5 Rossmeisl M., "Variation in type 2 diabetes-related traits in mouse strains susceptible to dietinduced obesity" 52 : 1958-1966, 2003
6 Wu L., "Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450" 312 : 35-43, 2005
7 Ishii T., "Transcription factor Nrf2 coordinately regulates a group of oxidative stressinducible genes in macrophages" 275 : 16023-16029, 2000
8 Wortham M., "The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet" 53 : 2761-2774, 2008
9 Dobrzyn A., "The role of stearoyl-CoA desaturase-1 in the control of metabolism" 73 : 35-41, 2005
10 Liu JY, "The protective effects of Hibiscus sabdariffa extract on CCl4- induced liver fibrosis in rats" 44 : 336-343, 2006
11 Staib F., "The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress" 65 : 10255-10264, 2005
12 McGarry JD, "The mitochondrial carnitine palmitoyltransferase system" 2441 : 2514-, 1997
13 Han ES, "The in vivo gene expression signature of oxidative stress" 34 : 112-126, 2008
14 Janowski BA, "The hypocholesterolemic agent LY295427 upregulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP" 99 : 12675-12680, 2002
15 Cong WN, "The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice" 82 : 983-990, 2008
16 Wamelink MM, "The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review" 31 : 703-717, 2008
17 Levine A., "The P53 pathway: what questions remain to be explored?" 13 : 1027-1036, 2006
18 Epstein WW, "Studies on the mechanism of squalene biosynthesis. The structures of presqualene pyrophosphate" 245 : 4597-4605, 1970
19 Suzuki H., "Structure and regulation of rat long-chain acyl-CoA synthetase" 265 : 8681-8685, 1990
20 Smith S., "Structural and functional organization of the animal fatty acid synthase" 42 : 289-317, 2003
21 Haniu M., "Structural and functional analysis of NADPH-cytochrome P- 450 reductase from human liver: complete sequence of human enzyme and NADPH-binding sites" 28 : 8639-8645, 1989
22 Zitzer H., "Sterol regulatory element-binding protein 1 mediates liver X receptor-b-induced increases in insulin secretion and insulin messenger ribonucleic acid levels" 147 : 3898-3905, 2006
23 Chan MY, "Sequential responses to high-fat and high-calorie feeding in an obese mouse model" 16 : 972-978, 2008
24 von Mering C., "STRING 7?recent developments in the integration and prediction of protein interactions" 35 : D358-D362, 2007
25 Ide T., "SREBPs suppress IRS-2-mediated insulin signalling in the liver" 6 : 351-357, 2004
26 Kohjima M., "SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease" 21 : 507-511, 2008
27 Morris DL, "SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins" 58 : 2039-2047, 2009
28 Mato JM, "S-Adenosylmethionine synthesis: molecular mechanisms and clinical implications" 73 : 265-280, 1997
29 Sparrow D, "Relationship of fat distribution to glucose tolerance" 35 : 411-415, 1986
30 Goldstein JL, "Regulation of the mevalonate pathway" 343 : 425-430, 1990
31 Hardie DG, "Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase" 30 : 1064-1070, 2002
32 Ji H., "Reduced capacity for fatty acid oxidation in rats with inherited susceptibility to diet-induced obesity" 56 : 1124-1130, 2007
33 Ntambi JM, "Recent insights into stearoyl-CoA desaturase-1" 14 : 255-261, 2003
34 Kohjima M., "Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease" 20 : 351-358, 2007
35 Jeoung NH, "Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice" 295 : E46-E54, 2008
36 Hwang BH, "Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet" 423 : 243-252, 2009
37 Doege H., "Protein-mediated fatty acid uptake: novel insights from in vivo models" 21 : 259-268, 2006
38 Bavenholm P., "Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function" 19 : 402-410, 1998
39 Kohler HP, "Plasminogen-activator inhibitor type 1 and coronary artery disease" 342 : 1792-1801, 2000
40 Kim JH, "Phospholipase D2 directly interacts with aldolase via its PH domain" 41 : 3414-3421, 2002
41 Hsu CL, "Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats" 57 : 425-431, 2009
42 Yu S., "Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis" 3 : 561-572, 2003
43 Kersten S., "Peroxisome proliferator activated receptors and obesity" 440 : 223-234, 2002
44 Suzuki Y., "Peroxisomal acyl CoA oxidase deficiency" 140 : 128-130, 2002
45 Evans RM, "PPARs and the complex journey to obesity" 10 : 355-361, 2004
46 Kohen R., "Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification" 30 : 620-650, 2002
47 Haslam DW, "Obesity" 9492 : 1197-1209, 2005
48 Maxwell KN, "Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice" 44 : 2109-2119, 2003
49 Salomaa V., "Noninsulin- dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study" 91 : 1432-1443, 1995
50 Diehl AM, "Nonalcoholic steatohepatitis" 19 : 220-229, 1999
51 Cave M., "Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition" 18 : 184-195, 2007
52 Browning JD, "Molecular mediators of hepatic steatosis and liver injury" 114 : 147-152, 2004
53 Bhattacharya S., "Molecular mechanism of insulin resistance" 32 : 405-413, 2007
54 Aoyama T., "Molecular cloning and functional expression of a human peroxisomal acyl-coenzyme A oxidase" 198 : 1113-1118, 1994
55 Ve´rtessy BG, "Modulation of the interaction between aldolase and glycerol-phosphate dehydrogenase by fructose phosphates" 1078 : 236-242, 1991
56 Millward CA, "Mice with a deletion in the gene for CCAAT/enhancer-binding protein b are protected against diet-induced obesity" 56 : 161-167, 2007
57 Kang YJ, "Metallothionein redox cycle and function" 231 : 1459-1467, 2006
58 Dong F., "Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis" 56 : 2201-2212, 2007
59 Oh HT, "Masou salmon (Oncorhynchus masou) ethanol extract decreases 3-hydroxy-3- methylglutaryl coenzyme A reductase expression in diet-induced obese mice" 29 : 123-129, 2009
60 Ntambi JM, "Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity" 99 : 11482-11486, 2002
61 Gu J., "Liver-specific deletion of the NADPH-cytochrome P450 reductase gene. Impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase" 278 : 25895-25901, 2003
62 Sohet FM, "Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice" 102 : 462-469, 2009
63 Sobel BE, "Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis" 23 : 1979-1989, 2003
64 Hill JO, "International strategies to address obesity" 9 : 41-47, 2008
65 Lee PDK, "Insulin-like growth factor binding protein-1: recent findings and new directions" 216 : 319-357, 1997
66 Kotronen A., "Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity" 93 : 4867-4872, 2008
67 Mogul HR, "Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women" 81 : 4492-4495, 1996
68 Zhao H., "Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice" 50 : 85-93, 2009
69 Matsui N., "Ingested cocoa can prevent high-fat diet?induced obesity by regulating the expression of genes for fatty acid metabolism" 21 : 594-601, 2005
70 de Maat MP, "Inflammation, thrombosis and atherosclerosis: results of the Glostrup study" 1 : 950-957, 2003
71 Schoonjans K., "Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is medicated by a peroxisome proliferator response element in the C promoter" 270 : 19269-19276, 1995
72 Matsuzawa-Nagata N., "Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity" 57 : 1071-1077, 2008
73 Visinoni S., "Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver" 295 : E1132-E1141, 2008
74 Inoue M., "Increased expression of PPARg in high fat diet-induced liver steatosis in mice" 336 : 215-222, 2005
75 Paradis V., "In situ detection of lipid peroxidation byproducts in chronic liver diseases" 26 : 135-142, 1997
76 Kwon DY, "Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats" 139 : 63-68, 2008
77 Andrikopoulos S., "Impaired regulation of hepatic fructose-1,6-biphosphatase in the New Zealand Obese mouse: an acquired defect" 45 : 622-626, 1996
78 Antonenkov VD, "Identification, purification and characterization of an acetoacetyl-CoA thiolase from rat liver peroxisomes" 267 : 2981-2990, 2000
79 Zhang L., "Hypoxia-regulated p53 and its effect on radiosensitivity in cancer cells" 83 : 443-456, 2007
80 Hamelet J., "Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice" 46 : 151-159, 2007
81 Jayakumar A., "Human fatty acid synthase: properties and molecular cloning" 92 : 8695-8699, 1995
82 Mantena SK, "High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo" 417 : 183-193, 2009
83 Dutta R., "Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes" 169 : 51-62, 2003
84 Kim SJ, "Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model" 340 : 99-109, 2004
85 Leu JI, "Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria" 21 : 3095-3109, 2007
86 Yoshinari K., "Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet" 23 : 1188-1200, 2006
87 Andrews MT, "Genes controlling the metabolic switch in hibernating mammals" 32 : 1021-1024, 2004
88 Maloney CA, "Gene-nutrient interactions during fetal development" 130 : 401-410, 2005
89 Boden G., "Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction" 32 : 14-23, 2002
90 Wolfrum C., "Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes" 432 : 1027-1032, 2004
91 Wolfrum C., "Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes" 432 : 1027-1032, 2003
92 Juhan-Vague I., "Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris" 94 : 2057-2063, 1996
93 Folsom AR, "Fibrinogen, plasminogen activator inhibitor- 1, and carotid intima-media wall thickness in the NHLBI Family Heart Study" 79 : 400-404, 1998
94 Aasum E., "Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice" 44 : 201-209, 2008
95 Kuhajda FP, "Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology" 16 : 202-208, 2000
96 Petro AE, "Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse" 53 : 454-457, 2004
97 Ramakrishna S., "Fat cell protein phosphorylation. Identification of phosphoprotein-2 as ATP-citrate lyase" 254 : 9232-9236, 1979
98 Zhou Y., "Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats" 295 : F662-F671, 2008
99 Lee KY, "Effect of exercise on hepatic gene expression in an obese mouse model using cDNA microarrays" 14 : 1294-1302, 2006
100 Youn-Soo Cha, "Effect of Genistein with Carnitine Administration on Lipid Parameters and Obesity in C57Bl/6J Mice Fed a High-Fat Diet" 한국식품영양과학회 9 (9): 459-467, 2006
101 Cattel L., "Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase" 53 : 363-391, 1989
102 Kondo H., "Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice" 291 : E1092-E1099, 2006
103 Surwit RS, "Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice" 44 : 645-651, 1995
104 Sakuma T., "Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat" 31 : 223-237, 2001
105 Murase T., "Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice" 42 : 372-378, 2001
106 Sohet FM, "Diet-induced obesity is associated with hyperleptinemia, hyperinsulinemia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice" 36 : 311-325, 2009
107 Gregoire FM, "Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM- 1-deficient mice" 282 : E703-E713, 2002
108 Van Heek M, "Diet-induced obese mice develop peripheral, but not central, resistance to leptin" 99 : 385-390, 1997
109 Lin S., "Development of high fat diet-induced obesity and leptin resistance in C57BI/6J mice" 24 : 639-646, 2000
110 Kunau WH, "Degradation of unsaturated fatty acids. Identification of intermediates in the degradation of cis-4-decenoyl-CoA by extracts of beef-liver mitochondria" 91 : 533-544, 1978
111 Carmona MC, "Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBP-beta" 389 : 47-56, 2005
112 Oren M., "Decision making by p53: life, death and cancer" 10 : 431-442, 2003
113 Lopez IP, "DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats" 11 : 188-194, 2003
114 Yang T., "Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER" 110 : 489-500, 2002
115 Niemela O., "Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation" 70 : 537-546, 1994
116 Martin G., "Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARa and PPARg activators" 272 : 28210-28217, 1997
117 Taniguchi CM, "Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism" 115 : 718-727, 2005
118 Sohet FM, "Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice" 78 : 1391-1400, 2009
119 Berg JM, "Chapter 16, Glycolysis and gluconeogenesis, In: Biochemistry, 6th ed" W.H. Freeman and Co 433-474, 2002
120 Kovacs WJ, "Central role of peroxisomes in isoprenoid biosynthesis" 41 : 369-391, 2002
121 Krisans SK, "Cell compartmentalization of cholesterol biosynthesis" 804 : 142-164, 1996
122 Park YM, "CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima" 119 : 136-145, 2009
123 Ericsson J., "Biosynthesis of dolichol and cholesterol in rat liver peroxisomes" 75 : 167-173, 1993
124 Murase T., "Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver" 26 : 1459-1464, 2002
125 Raval J., "Basal reactive oxygen species determine the susceptibility to apoptosis in cirrhotic hepatocytes" 41 : 1645-1654, 2006
126 Enriquez A., "Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats" 255 : 300-306, 1999
127 Wu P., "Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha" 287 : 391-396, 2001
128 Scheja L., "Acute-phase serum amyloid A as a marker of insulin resistance in mice" 2008 : ID 230837-, 2008
129 Kondoh N., "Activation of a system A amino acid transporter, ATA1/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues" 31 : 81-87, 2007
130 Kondo T., "Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation" 57 : 5982-5986, 2009
131 Choi HJ, "A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model" 359 : 419-425, 2007
132 Roe CR, "2,4-Dienoylcoenzyme A reductase deficiency: a possible new disorder of fatty acid oxidation" 85 : 1170-1703, 1990